Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials
- Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH
- Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy
- An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain
- Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient
- Metabolic Response of Glioblastoma to Superselective Intra-Arterial Cerebral Infusion of Bevacizumab: A Proton MR Spectroscopic Imaging Study
- Characteristics of Oral Mucosal Events Related to Bevacizumab Treatment